ZW4864 free base

CAS No. 2632259-92-6

ZW4864 free base( —— )

Catalog No. M37644 CAS No. 2632259-92-6

ZW4864 (free base) is an orally active and selective β-catenin/B-Cell lymphoma 9 protein-protein interaction (β-catenin/BCL9 PPI) inhibitor, with a K_i value of 0.76 μM and an IC_50 value of 0.87 μM .

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 432 In Stock
5MG 392 In Stock
10MG 587 In Stock
25MG 936 In Stock
50MG 1237 In Stock
100MG 1665 In Stock
200MG Get Quote In Stock
500MG 3339 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    ZW4864 free base
  • Note
    Research use only, not for human use.
  • Brief Description
    ZW4864 (free base) is an orally active and selective β-catenin/B-Cell lymphoma 9 protein-protein interaction (β-catenin/BCL9 PPI) inhibitor, with a K_i value of 0.76 μM and an IC_50 value of 0.87 μM .
  • Description
    ZW4864 (free base) is an orally active and selective β catenin/B-Cell lymphoma 9 protein protein interaction (β catenin/BCL9 PPI) inhibitor. ZW4864 (free base) inhibits β catenin/BCL9 PPI with a Ki value of 0.76 μM and an IC50 value of 0.87 μM.
  • In Vitro
    Western Blot Analysis Cell Line:SW480 and MBA-MD-231 cells Concentration:10~40 μM Incubation Time:24 hours Result:Decreased the expression levels of Axin2 and cyclin D1 proteins.Apoptosis Analysis Cell Line:MDA-MB231, MCF10A and MDA-MB-468 cells Concentration:10~40 μM Incubation Time:72 hours Result:Selectively triggered rapid apoptosis of triple-negative breast cancer cells with hyperactive β-catenin signaling while sparing normal mammary epithelial MCF10A cells.RT-PCR Cell Line:SW480 and MBA-MD-231 cells Concentration:10~40 μ Incubation Time:24 hours Result:Suppressed the transcription of β-catenin target genes in a concentration-dependent manner without affecting the expression of HPRT, a house-keeper gene, in both SW480 and Wnt 3a-activated MDA-MB-231 cells.
  • In Vivo
    Animal Model:C57BL/6 mice Dosage:20 mg/kg (Pharmacokinetic Analysis)Administration:P.o.Result:Exhibited good pharmacokinetic properties with an oral bioavailability (F) of 83%.Animal Model:Mice Dosage:90 mg/kg Administration:P.o.Result:Showed a variation in tumor growth in mice.
  • Synonyms
    ——
  • Pathway
    Wnt/Notch/Hedgehog
  • Target
    Wnt/beta/catenin
  • Recptor
    Wnt/beta-catenin
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2632259-92-6
  • Formula Weight
    570.72
  • Molecular Formula
    C33H42N6O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (175.22 mM; Ultrasonic )
  • SMILES
    CC(C)(Oc1cccc(c1)N1CCC[C@H](C1)C(=O)N(Cc1ccc(cc1)-c1cn[nH]c1)C1CC1)C(=O)N1CCNCC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Wang Z, et al. Discovery of an Orally Bioavailable Small-Molecule Inhibitor for the β-Catenin/B-Cell Lymphoma 9 Protein-Protein Interaction. J Med Chem. 2021;64(16):12109-12131.?
molnova catalog
related products
  • WIC1

    WIC1 is a potent Wnt inhibitor. WIC1 can be used in cancer research

  • Zinc Orotate

    Orotic acid zinc salt dihydrate is an intermediate product in pyrimidine synthesis.

  • Vantictumab

    Vantictumab (OMP-18R5) is a humanized anti-FZD1/2/5/7/8 monoclonal antibody that inhibits Wnt pathway signaling and is used in research studies for the treatment of metastatic HER2-negative breast cancer and metastatic pancreatic adenocarcinoma.